Нивата на лекарството в тялото се увеличават с всяка следваща инжекция и след около шест инжекции се достига устойчиво ниво.
Faslodex has been studied in two main studies involving a total of 1,014 postmenopausal women with advanced breast cancer that had come back or got worse after previous hormonal treatment.